Rani Therapeutics to Join Evercore Healthcare Conference
Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), based in San Jose, is excited to announce its participation in the Evercore Healthcare Conference where its management will share insights into their innovative approaches in the biotherapeutics realm. This esteemed event will feature the company’s leaders engaging in a discussion designed for investors and industry enthusiasts alike.
Event Details
The 8th Annual Evercore Healthcare Conference is scheduled for Wednesday, December 3 at 8:45 am E.T. The setting will foster an interactive experience, as Chief Executive Officer Talat Imran and Chief Financial Officer Svai Sanford lead a fireside chat, complemented by personalized 1x1 meetings. This format promotes a unique opportunity for stakeholders to delve deeper into Rani’s strategic initiatives.
Understanding Rani Therapeutics
Rani Therapeutics stands at the forefront of biotherapeutic innovation, concentrating on technologies that facilitate the oral delivery of biologics and medications. Their proprietary RaniPill capsule exemplifies this commitment, designed specifically to replace traditional methods of administering drugs—such as injections—with more convenient oral dosing. This groundbreaking approach not only enhances patient comfort but also has the potential to improve compliance and outcomes.
Innovative Technology
At the core of Rani’s mission is the RaniPill capsule, a patented platform that transforms how biologics are delivered. By conducting a series of rigorous preclinical and clinical trials, Rani Therapeutics has successfully demonstrated the safety and bioavailability of its oral dosage forms. The ongoing advancements in this technology could revolutionize treatment modalities for various conditions, making it a topic of great interest at healthcare forums like the Evercore Conference.
Engaging with Stakeholders
For those interested in this conference, Rani Therapeutics invites you to access the live webcast through their Investor Relations section on their website. The replay will be available following the session, allowing interested individuals to absorb the insights shared during the presentation.
Contact for Investors and Media
Communication remains a priority for Rani Therapeutics. Investors or members of the media seeking further information can reach out via the company's dedicated email contacts. For investors, the address is investors@ranitherapeutics.com. For media inquiries, they can connect at media@ranitherapeutics.com.
Frequently Asked Questions
What is the purpose of Rani Therapeutics' participation in the conference?
The participation showcases Rani's innovative technologies in oral delivery of biologics and engages with investors and industry experts.
Who will be presenting at the conference?
CEO Talat Imran and CFO Svai Sanford will represent Rani Therapeutics during the event.
What technology does Rani Therapeutics focus on?
Rani Therapeutics specializes in oral administration technologies for biologics, particularly through their proprietary RaniPill capsule.
How can interested parties access the conference?
The conference webcast can be accessed from the Investor Relations section on Rani's website.
How can I get in touch with Rani Therapeutics?
Investors can reach the company at investors@ranitherapeutics.com and media inquiries can be sent to media@ranitherapeutics.com.
